1,400 Shares in The Clorox Company (NYSE:CLX) Bought by Baker Ellis Asset Management LLC

Baker Ellis Asset Management LLC purchased a new stake in The Clorox Company (NYSE:CLX) in the first quarter, Holdings Channel.com reports. The fund purchased 1,400 shares of the company’s stock, valued at approximately $214,000.

A number of other institutional investors and hedge funds have also bought and sold shares of CLX. Federated Hermes Inc. raised its position in Clorox by 16.4% in the 3rd quarter. Federated Hermes Inc. now owns 4,744 shares of the company’s stock valued at $622,000 after buying an additional 670 shares during the last quarter. Mutual Advisors LLC raised its position in Clorox by 23.2% in the 3rd quarter. Mutual Advisors LLC now owns 3,803 shares of the company’s stock valued at $498,000 after buying an additional 717 shares during the last quarter. Tower Research Capital LLC TRC raised its position in Clorox by 93.5% in the 3rd quarter. Tower Research Capital LLC TRC now owns 13,793 shares of the company’s stock valued at $1,808,000 after buying an additional 6,663 shares during the last quarter. Bank of Nova Scotia raised its position in Clorox by 237.7% in the 3rd quarter. Bank of Nova Scotia now owns 36,232 shares of the company’s stock valued at $4,749,000 after buying an additional 25,502 shares during the last quarter. Finally, Nomura Holdings Inc. raised its position in Clorox by 12.1% in the 3rd quarter. Nomura Holdings Inc. now owns 7,971 shares of the company’s stock valued at $1,045,000 after buying an additional 861 shares during the last quarter. 78.53% of the stock is owned by hedge funds and other institutional investors.

Clorox Trading Down 0.1 %

Shares of CLX opened at $136.47 on Friday. The Clorox Company has a fifty-two week low of $114.68 and a fifty-two week high of $169.14. The business has a 50-day moving average of $136.95 and a 200 day moving average of $143.80. The company has a debt-to-equity ratio of 9.73, a quick ratio of 0.53 and a current ratio of 0.90. The firm has a market cap of $16.95 billion, a P/E ratio of 70.71, a price-to-earnings-growth ratio of 2.19 and a beta of 0.39.

Clorox (NYSE:CLX) last issued its earnings results on Tuesday, April 30th. The company reported $1.71 EPS for the quarter, topping the consensus estimate of $1.33 by $0.38. Clorox had a return on equity of 302.49% and a net margin of 3.33%. The business had revenue of $1.81 billion during the quarter, compared to the consensus estimate of $1.87 billion. During the same quarter last year, the company earned $1.51 EPS. The firm’s revenue was down 5.3% compared to the same quarter last year. As a group, research analysts forecast that The Clorox Company will post 5.91 EPS for the current year.

Analyst Ratings Changes

Several equities research analysts have recently issued reports on the company. Evercore ISI decreased their target price on Clorox from $145.00 to $142.00 and set an “underperform” rating for the company in a research report on Wednesday, May 1st. UBS Group decreased their target price on Clorox from $164.00 to $159.00 and set a “neutral” rating for the company in a research report on Wednesday, May 1st. BNP Paribas assumed coverage on Clorox in a research report on Monday, June 24th. They set an “underperform” rating and a $130.00 target price for the company. DA Davidson reaffirmed a “neutral” rating and set a $162.00 target price on shares of Clorox in a research report on Wednesday, April 17th. Finally, Deutsche Bank Aktiengesellschaft decreased their target price on Clorox from $155.00 to $151.00 and set a “hold” rating for the company in a research report on Wednesday, April 17th. Five analysts have rated the stock with a sell rating and fourteen have issued a hold rating to the company. According to MarketBeat.com, the company presently has an average rating of “Hold” and an average price target of $145.33.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.